Healthcare Infection Control Practices Advisory Committee (HICPAC) Meeting, 35094 [2021-14008]
Download as PDF
<![CDATA[
35094
Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–14007 Filed 6–30–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC) Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by audio and
web conference lines (300 audio and
web conference lines are available).
Registration is required. To register for
this web conference, please go to:
www.cdc.gov/hicpac. All registered
participants will receive the meeting
link and instructions shortly before the
meeting.
DATES: The meeting will be held on
August 19, 2021, from 12:00 p.m. to 2:00
p.m., EDT.
ADDRESSES: Please click the link below
to join the webinar: https://
cdc.zoomgov.com/j/1612908106?
pwd=M0xTVWxmUTRtZXhu
OVBzWmsybFZxZz09.
Meeting ID: 161 290 8106
Passcode: yq!BLL44
Dial-in Lines:
+1–669–254–5252 (San Jose)
+1–646–828–7666 (New York)
Meeting ID: 161 290 8106
Telephone Passcode: 47632330.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, 1600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027; Telephone: (404)
498–0730; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:45 Jun 30, 2021
Jkt 253001
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; the Isolation Precautions
Guideline Workgroup; and the Neonatal
Intensive Care Unit Workgroup. Agenda
items are subject to change as priorities
dictate.
Procedures for Public Comment: Time
will be available for public comment.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments.
Procedures for Written Comment: The
public may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is July 26, 2021. All requests
must contain the name, address, and
organizational affiliation of the speaker,
as well as the topic being addressed.
Written comments should not exceed
one single-spaced typed page in length.
Written comments received in advance
of the meeting will be included in the
official record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–14008 Filed 6–30–21; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10516]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by August 2, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at:
https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
DATES:
E:\FR\FM\01JYN1.SGM
01JYN1
]]>Agencies
[Federal Register Volume 86, Number 124 (Thursday, July 1, 2021)]
[Notices]
[Page 35094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14008]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC) Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This virtual meeting is open to
the public, limited only by audio and web conference lines (300 audio
and web conference lines are available). Registration is required. To
register for this web conference, please go to: www.cdc.gov/hicpac. All
registered participants will receive the meeting link and instructions
shortly before the meeting.
DATES: The meeting will be held on August 19, 2021, from 12:00 p.m. to
2:00 p.m., EDT.
ADDRESSES: Please click the link below to join the webinar: https://cdc.zoomgov.com/j/1612908106?pwd=M0xTVWxmUTRtZXhuOVBzWmsybFZxZz09.
Meeting ID: 161 290 8106
Passcode: yq!BLL44
Dial-in Lines:
+1-669-254-5252 (San Jose)
+1-646-828-7666 (New York)
Meeting ID: 161 290 8106
Telephone Passcode: 47632330.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027; Telephone: (404)
498-0730; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; the Isolation
Precautions Guideline Workgroup; and the Neonatal Intensive Care Unit
Workgroup. Agenda items are subject to change as priorities dictate.
Procedures for Public Comment: Time will be available for public
comment. Members of the public who wish to provide public comments
should plan to attend the public comment session at the start time
listed. Please note that the public comment period may end before the
time indicated, following the last call for comments.
Procedures for Written Comment: The public may submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed above. The deadline for
receipt of written public comment is July 26, 2021. All requests must
contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length. Written comments
received in advance of the meeting will be included in the official
record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14008 Filed 6-30-21; 8:45 am]
BILLING CODE 4163-18-P
